Study provides the first comprehensive look of pediatric preventive cardiology care

Today in the U.S., a child with risk factors for heart disease (high blood pressure, overweight, etc.) can wait close to a year to see a cardiologist because of high demand and limited resources.

What ever happened to biotech’s big comeback?

This was supposed to be the year of the biotech comeback, when promising new medicines and high-dollar buyouts would reverse a sector-wide slump that dates

September 25, 2023

Risk Adjusted Net Present Value: What is the current valuation of PMV Pharmaceuticals’s Rezatapopt

The revenue for Rezatapopt is expected to reach an annual total of $63 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

OU scientists receive $1.8 million to establish research center to address children’s health impacts from environmental stressors

OU researchers have received a $1.8 million grant from the U.S. Environmental Protection Agency to establish a research center to address children’s cumulative health impacts

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.